Patent · US Active

Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample

US10489550B2 · kind B2 · utility

10Cited by
7References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 12, 2017
Grant dateNov 26, 2019
Priority date
Expiry dateApr 7, 2038

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH01J49/0036
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A programmed computer functioning as a classifier operates on mass spectral data obtained from a blood-based patient sample to predict indolence or aggressiveness of prostate cancer. Methods of generating the classifier and conducting a test on a blood-based sample from a prostate cancer patient using the classifier are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.